Molnupiravir: A welcome development but accessibility still a question

Dr. Satyajit Rath talks about key aspects of the new drug, Molnupiravir, and points out that a lot that needs attention to make sure the drug becomes accessible to the poorer nations

October 13, 2021 by Newsclick

In this episode of the Covid Show, Dr. Satyajit Rath discusses the complex political economy of coronavirus drugs. He tries to answer popular questions surrounding the new drug, Molnupiravir, and claims that the new drug is a welcome development. But, he also believes that there is still a lot that needs attention to make sure the drug becomes accessible to the poorer nations.